Investment
Features
FeesSafety
Academy
More
Pluang+

Compare DexCom, Inc. (DXCM) vs Suncor Energy Inc. (SU) Price & Performance

DexCom, Inc.Trade
Suncor Energy Inc.Trade

Price performance (Past 24H)

Key statistics

DexCom, Inc. vs Suncor Energy Inc. — how do they compare? DexCom, Inc. trades at $84.8 (market cap $31.86B), while Suncor Energy Inc. trades at $70.92 (market cap $82.76B). The key difference: Suncor Energy Inc. is far larger — about 2.6× DexCom, Inc.'s market cap, and Suncor Energy Inc. pays a 2.39% dividend while DexCom, Inc. pays none. Which is the better fit depends on your goals — on Pluang, investors hold DexCom, Inc. for 62 Days and Suncor Energy Inc. for 57 Days on average.

DXCMSU
Market Cap
$31.86B$82.76B
Volume
3,607,0703,832,959
Sector
HealthEnergy
52-Week High
$92.34$71.87
52-Week Low
$54.84$38.17
Typical Hold Time
62 Days57 Days
Enterprise Value
$31.32B$89.29B
Dividend Yield
—2.39%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

DexCom, Inc.

DXCM trades at $84.3, up 1.09% today, with a bearish technical signal despite strong fundamentals. The company reported Q2 2026 EPS of $0.70, beating estimates, continuing a trend of earnings outperformance. Revenue growth is robust, with 2025 revenue reaching $4.66 billion and net income margin improving to 20.12%. Analyst consensus is strongly bullish with an 80.77% buy rating and a $95.07 price target, suggesting significant upside from current levels.

The outlook for DXCM is positive driven by expansion in continuous glucose monitoring for Type 2 diabetes, as highlighted in recent company reports. Key risks include competitive pressures and reimbursement challenges. With solid cash flow generation and institutional support, the stock presents a growth opportunity, though investors should monitor execution against high expectations.

Suncor Energy Inc.

Suncor Energy (SU) trades at $68.14, down slightly by 0.12% on the day. The stock exhibits a bullish technical trend, supported by strong fundamentals including a P/E of 13.46 and a net income margin of 14.7%. Recent Q2 2026 earnings beat expectations, and the company announced a $0.60 dividend for H2-2026. Analyst consensus is strongly positive with 23 buy ratings and no sell recommendations. News highlights include asset divestments and a planned CEO transition to Peter Zebedee in 2027.

The outlook for SU is favorable, driven by robust cash flow, aggressive shareholder returns via buybacks and dividends, and a discounted valuation relative to peers. Key risks include commodity price volatility, operational disruptions from weather events, and execution of the leadership transition. The stock's current price near recent highs suggests momentum, but investors should weigh these factors against the strong fundamental backdrop.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

DXCM
100% Buy0% Sell
Avg holding period · 62 Days
SU
40% Buy60% Sell
Avg holding period · 57 Days

Top news

Latest headlines on both assets

About DexCom, Inc.

Dexcom designs and commercializes continuous glucose monitoring systems for diabetics. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to include the disposable sensor and the durable receiver.

Read more on DXCM →

About Suncor Energy Inc.

Suncor Energy Inc is an integrated energy company. The company's operations include oil sands development, production and upgrading, offshore oil and gas, petroleum refining in Canada and the U.S. and the company's PetroCanada retail and wholesale distribution networks. The company is developing petroleum resources while advancing the transition to a low-emissions future through investment in power, renewable fuels and hydrogen. It also conducts energy trading activities focused principally on the marketing and trading of crude oil, natural gas, byproducts, refined products and power.

Read more on SU →